Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

Abstract Cladribine tablets (CladT) is a highly active oral disease-modifying therapy (DMT) for the management of relapsing multiple sclerosis (RMS). CladT acts as an immune reconstitution therapy, in that two short courses of treatment 1 year apart have been shown to suppress disease activity for a...

Full description

Bibliographic Details
Main Authors: Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, Jerome De Sèze, Patrick Vermersch, Ali-Frederic Ben-Amor, Carine Savarin, Gilles Defer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-06-01
Series:Neurology and Therapy
Subjects:
Multiple sclerosis
Cladribine tablets
Disease-modifying therapy
Immune reconstitution therapy
Drug safety
Online Access:https://doi.org/10.1007/s40120-023-00496-3

Internet

https://doi.org/10.1007/s40120-023-00496-3

Similar Items